2.3% Excise Tax Goes Into Effect in 2013; FDA Registration Fees Increase

Patrick Tessier · September 5, 2012

It is now clear that both the FDA and the IRS considers in-office milling to be medical device manufacturing. So the next question is: when are we going to tell our valued clients? For sure Patterson is not disclosing this to their Cerec clients. It should be up to the NADL to present this critical information to the ADA. If you knew your client was going to be hit by a truck, wouldn't you tell him?